TellgenplexTM Tumor Marker Test Base on suspension bead array method, Tellgen developed TellgenplexTM  Tellgen Tumor Marker Test which is intended for the simultaneous quantitative determination of 18 most common use tumor markers. The customers could select these markers independently or combine them together according to their needs. The kit could apply in both clinical test and personnel physical test, and became a high-end product in tumor markers detection area. Markers available AFP、CEA、CA242、CA125、NSE、CYFRA21-1、free-β-hCG、total-PSA、free-PSA、CA19-9、CA15-3、CA50、SCCA、HE4、PGI、PGII、ProGRP、CA72-4

Shanghai Tellgen Corporation. was founded in 2003 and dedicated exclusively to the development, production and distribution of high-quality automated workflow solutions for research and clinical diagnostics laboratories in the life sciences sector. With the tremendous development, Tellgen became the the market leader in moleucular diagnosis area, and had consistently delivered series diagnostic products for healthcare